PByT expands cancer treatment using AI for better outcomes

The world’s first trial of creating the most comprehensive database of information about cancer treatment utilizing AI

Sydney, Australia – Online service PByT, which stands for Powered by Trust, is inviting both cancer patients and medical practitioners to participate in the world’s first trial of creating the most comprehensive database of information about cancer treatment utilizing AI.

This will provide not only an easily accessible resource for the newly diagnosed cancer patients but also a new way for medical professionals, researchers and cancer patients to work together in developing, assessing and recommending strategies for the best possible outcomes. This will begin to break down the walls between the various disciplines, between patients and medical professionals and between the conventional practitioners and those advocating more holistic or complimentary approaches to the treatment and prevention of cancer.

At the moment, information on cancer treatment is all over the place – online forums, in books, booklets and pamphlets, in support groups, in the heads of the medical profession and, most importantly, in the heads of cancer survivors.

Cancer support groups are great, but imagine a support group of millions of people with information filtered, analyzed and presented instantly through the concept of AI, tailored to suit individual circumstances. If nothing else, it would immediately relieve the stress of information overload on the mental attitude of the newly diagnosed, which is increasingly being seen as one of the most important elements in fighting the disease.

In 2020, 19 million people around the world received a cancer diagnosis. By 2040, that number is expected to reach 28 million with the poorer countries hardest hit. AI technology will ensure that anyone with an Internet connection can have access to the best information.

The cancer database will consist of the key questions added by members that relate to treatment, prevention and other relevant matters seeking feedback. The feedback is from verified members who provide personal details and other socioeconomic data which is used to analyze the responses and present the finding as easy-to-read gauges. (While the feedback is non-anonymous, personal details are not publicly available, shared or disclosed in any way, except in aggregate format.)

The feedback can be likened to a plebiscite on any question, except that it is open-ended with no end date. Anyone can join and provide feedback at any time and those who change their minds can also vote reflecting their changed viewpoint or new insight.

In short, it will create an ongoing feedback response reflecting the most up-to-date experience and understanding. This will provide AI not only a comprehensive database ideal for analysis but also a database which is continuously updated through live and ongoing interaction.

For the newly diagnosed cancer patients this will provide an immediate resource where they can find answers to their most pressing questions thus avoiding the stress of wading through online forums, reading research reports and other resources which can be confusing, contradictory and very often misleading.

The feedback process will empower cancer patients to become active participants in the process rather than be treated as passive recipients of diagnoses and treatments, including providing feedback on the quality of care and professionalism of their medical providers.

The quality of medical care feedback is vitally important in helping newly diagnosed cancer patients find the best practitioners without having to resort to unreliable online reviews and chat forums. This will weed out the medical profession's cowboys as well as expose those peddling miracle cures and false hope.

Importantly, the PByT project will provide a forum for discussing and analyzing the efficacy of complimentary and alternative treatments beyond the mainstream approach of cutting, poisoning or burning tumors.

Equally importantly, the PByT concept will provide a new source of cancer research funding through the PByT Social Capital Fund, which expands corporate social responsibility to include the funding of the nonprofit sector.

The new funding approach has the potential to deliver billions of extra dollars into cancer research beyond donations, philanthropy and government policy, while the feedback mechanism will ensure that the money is well spent.

Prostate Cancer

Check out some of the questions relating to prostate cancer by typing "cancer" in the search box and start contributing to the database by joining PByT and adding your feedback.